Syndrome des mouvements périodiques nocturnes des membres : Questions médicales fréquentes
Nom anglais: Nocturnal Myoclonus Syndrome
Descriptor UI:D020189
Tree Number:C10.886.659.618
Termes MeSH sélectionnés :
Platelet-Rich Plasma
Questions fréquentes et termes MeSH associés
Diagnostic
5
#1
Comment diagnostique-t-on ce syndrome ?
Le diagnostic repose sur l'observation des mouvements nocturnes et des études du sommeil.
Syndrome des mouvements périodiquesPolysomnographie
#2
Quels tests sont utilisés pour le diagnostic ?
La polysomnographie est le test principal pour évaluer les mouvements et les cycles de sommeil.
PolysomnographieTroubles du sommeil
#3
Quels critères sont utilisés pour le diagnostic ?
Les critères incluent la fréquence des mouvements et leur impact sur la qualité du sommeil.
Syndrome des mouvements périodiquesQualité du sommeil
#4
Le syndrome est-il confondu avec d'autres troubles ?
Oui, il peut être confondu avec le syndrome des jambes sans repos ou d'autres troubles du sommeil.
Syndrome des jambes sans reposTroubles du sommeil
#5
Les antécédents médicaux influencent-ils le diagnostic ?
Oui, des antécédents de troubles du sommeil ou neurologiques peuvent influencer le diagnostic.
Antécédents médicauxTroubles neurologiques
Symptômes
5
#1
Quels sont les symptômes principaux ?
Les symptômes incluent des mouvements involontaires des membres et des réveils fréquents.
Mouvements involontairesRéveils nocturnes
#2
Les mouvements se produisent-ils à des moments précis ?
Oui, ils se produisent généralement pendant les phases de sommeil léger.
Phases de sommeilSommeil léger
#3
Y a-t-il des douleurs associées aux mouvements ?
Les mouvements peuvent causer des douleurs ou de l'inconfort, perturbant le sommeil.
DouleurPerturbation du sommeil
#4
Les symptômes varient-ils d'une personne à l'autre ?
Oui, l'intensité et la fréquence des mouvements peuvent varier considérablement.
Variabilité des symptômesTroubles du sommeil
#5
Les symptômes affectent-ils la qualité de vie ?
Oui, ils peuvent entraîner une fatigue diurne et affecter la qualité de vie globale.
Fatigue diurneQualité de vie
Prévention
5
#1
Peut-on prévenir ce syndrome ?
Il n'existe pas de méthode de prévention garantie, mais une bonne hygiène du sommeil peut aider.
PréventionHygiène du sommeil
#2
Le stress influence-t-il le syndrome ?
Oui, le stress peut aggraver les symptômes, donc la gestion du stress est conseillée.
StressGestion du stress
#3
L'alimentation joue-t-elle un rôle ?
Une alimentation équilibrée peut contribuer à un meilleur sommeil et réduire les symptômes.
Alimentation équilibréeSommeil
#4
L'exercice physique aide-t-il ?
Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire les mouvements nocturnes.
Exercice physiqueQualité du sommeil
#5
Les habitudes de sommeil influencent-elles le syndrome ?
Oui, des habitudes de sommeil régulières peuvent aider à réduire l'incidence des mouvements.
Habitudes de sommeilMouvements nocturnes
Traitements
5
#1
Quels traitements sont disponibles ?
Les traitements incluent des médicaments comme les benzodiazépines et des thérapies comportementales.
BenzodiazépinesThérapies comportementales
#2
Les changements de mode de vie aident-ils ?
Oui, des changements comme une meilleure hygiène du sommeil peuvent réduire les symptômes.
Hygiène du sommeilChangements de mode de vie
#3
Les médicaments sont-ils toujours nécessaires ?
Pas toujours, certains patients peuvent gérer les symptômes avec des approches non médicamenteuses.
Approches non médicamenteusesGestion des symptômes
#4
Y a-t-il des effets secondaires aux traitements ?
Oui, certains médicaments peuvent provoquer des effets secondaires comme la somnolence.
Effets secondairesSomnolence
#5
Les traitements sont-ils efficaces à long terme ?
L'efficacité peut varier, et un suivi régulier est souvent nécessaire pour ajuster le traitement.
Suivi médicalEfficacité des traitements
Complications
5
#1
Quelles complications peuvent survenir ?
Les complications incluent la fatigue chronique et des troubles de l'humeur comme l'anxiété.
Fatigue chroniqueTroubles de l'humeur
#2
Le syndrome peut-il affecter la santé mentale ?
Oui, les troubles du sommeil peuvent contribuer à des problèmes de santé mentale.
Santé mentaleTroubles du sommeil
#3
Y a-t-il un risque accru d'autres maladies ?
Oui, les troubles du sommeil peuvent augmenter le risque de maladies cardiovasculaires.
Maladies cardiovasculairesTroubles du sommeil
#4
Les complications sont-elles réversibles ?
Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie.
RéversibilitéTraitement
#5
Comment les complications sont-elles gérées ?
La gestion des complications implique souvent une approche multidisciplinaire incluant médecins et psychologues.
Gestion des complicationsApproche multidisciplinaire
Facteurs de risque
5
#1
Quels sont les facteurs de risque connus ?
Les facteurs incluent l'âge avancé, des troubles neurologiques et des antécédents familiaux.
Âge avancéAntécédents familiaux
#2
Le sexe influence-t-il le risque ?
Oui, les hommes sont souvent plus touchés que les femmes par ce syndrome.
SexePrévalence
#3
Les troubles du sommeil augmentent-ils le risque ?
Oui, des troubles comme l'apnée du sommeil peuvent augmenter le risque de ce syndrome.
Apnée du sommeilTroubles du sommeil
#4
Les médicaments peuvent-ils être un facteur de risque ?
Oui, certains médicaments, comme les antidépresseurs, peuvent exacerber les symptômes.
AntidépresseursFacteurs de risque
#5
Le mode de vie influence-t-il le risque ?
Oui, un mode de vie sédentaire et une mauvaise hygiène du sommeil peuvent augmenter le risque.
Mode de vie sédentaireHygiène du sommeil
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome des mouvements périodiques nocturnes des membres : Questions médicales les plus fréquentes",
"headline": "Syndrome des mouvements périodiques nocturnes des membres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome des mouvements périodiques nocturnes des membres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2025-02-27",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome des mouvements périodiques nocturnes des membres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies du système nerveux",
"url": "https://questionsmedicales.fr/mesh/D009422",
"about": {
"@type": "MedicalCondition",
"name": "Maladies du système nerveux",
"code": {
"@type": "MedicalCode",
"code": "D009422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome des mouvements périodiques nocturnes des membres",
"alternateName": "Nocturnal Myoclonus Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D020189",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sterre van der Veen",
"url": "https://questionsmedicales.fr/author/Sterre%20van%20der%20Veen",
"affiliation": {
"@type": "Organization",
"name": "Pontificia Universidad Católica Argentina (UCA) Buenos Aires Argentina."
}
},
{
"@type": "Person",
"name": "Marina A J Tijssen",
"url": "https://questionsmedicales.fr/author/Marina%20A%20J%20Tijssen",
"affiliation": {
"@type": "Organization",
"name": "Department of Neurology University of Groningen, University Medical Center Groningen Groningen The Netherlands."
}
},
{
"@type": "Person",
"name": "Matthew R Epstein",
"url": "https://questionsmedicales.fr/author/Matthew%20R%20Epstein",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
},
{
"@type": "Person",
"name": "Kyle P Michelson",
"url": "https://questionsmedicales.fr/author/Kyle%20P%20Michelson",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
},
{
"@type": "Person",
"name": "Thomas F Monaghan",
"url": "https://questionsmedicales.fr/author/Thomas%20F%20Monaghan",
"affiliation": {
"@type": "Organization",
"name": "Department of Urology, SUNY Downstate Health Sciences University, Brooklyn, New York."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Platelet-rich plasma in chronic Achilles tendinopathy.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37225947",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00590-023-03570-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of platelet-rich plasma efficacy in melasma.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35852165",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14764172.2022.2099898"
}
},
{
"@type": "ScholarlyArticle",
"name": "Autologous platelet-rich plasma for assisted reproduction.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38682756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD013875.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Application of platelet-rich plasma in spinal surgery.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/37008931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1138255"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intradiscal Leukocyte Rich Platelet Rich Plasma for Degenerative Disc Disease.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36410879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pmr.2022.08.009"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Syndrome des mouvements périodiques nocturnes des membres",
"item": "https://questionsmedicales.fr/mesh/D020189"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome des mouvements périodiques nocturnes des membres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Comment diagnostique-t-on ce syndrome ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe syndrome est-il confondu avec d'autres troubles ?\nLes antécédents médicaux influencent-ils le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels sont les symptômes principaux ?\nLes mouvements se produisent-ils à des moments précis ?\nY a-t-il des douleurs associées aux mouvements ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Peut-on prévenir ce syndrome ?\nLe stress influence-t-il le syndrome ?\nL'alimentation joue-t-elle un rôle ?\nL'exercice physique aide-t-il ?\nLes habitudes de sommeil influencent-elles le syndrome ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels traitements sont disponibles ?\nLes changements de mode de vie aident-ils ?\nLes médicaments sont-ils toujours nécessaires ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils efficaces à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quelles complications peuvent survenir ?\nLe syndrome peut-il affecter la santé mentale ?\nY a-t-il un risque accru d'autres maladies ?\nLes complications sont-elles réversibles ?\nComment les complications sont-elles gérées ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome des mouvements périodiques nocturnes des membres",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes troubles du sommeil augmentent-ils le risque ?\nLes médicaments peuvent-ils être un facteur de risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D020189?mesh_terms=Platelet-Rich+Plasma#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on ce syndrome ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'observation des mouvements nocturnes et des études du sommeil."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "La polysomnographie est le test principal pour évaluer les mouvements et les cycles de sommeil."
}
},
{
"@type": "Question",
"name": "Quels critères sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent la fréquence des mouvements et leur impact sur la qualité du sommeil."
}
},
{
"@type": "Question",
"name": "Le syndrome est-il confondu avec d'autres troubles ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être confondu avec le syndrome des jambes sans repos ou d'autres troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de troubles du sommeil ou neurologiques peuvent influencer le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires des membres et des réveils fréquents."
}
},
{
"@type": "Question",
"name": "Les mouvements se produisent-ils à des moments précis ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils se produisent généralement pendant les phases de sommeil léger."
}
},
{
"@type": "Question",
"name": "Y a-t-il des douleurs associées aux mouvements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mouvements peuvent causer des douleurs ou de l'inconfort, perturbant le sommeil."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la fréquence des mouvements peuvent varier considérablement."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner une fatigue diurne et affecter la qualité de vie globale."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir ce syndrome ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention garantie, mais une bonne hygiène du sommeil peut aider."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le syndrome ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut aggraver les symptômes, donc la gestion du stress est conseillée."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut contribuer à un meilleur sommeil et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la qualité du sommeil et réduire les mouvements nocturnes."
}
},
{
"@type": "Question",
"name": "Les habitudes de sommeil influencent-elles le syndrome ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de sommeil régulières peuvent aider à réduire l'incidence des mouvements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments comme les benzodiazépines et des thérapies comportementales."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie aident-ils ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements comme une meilleure hygiène du sommeil peuvent réduire les symptômes."
}
},
{
"@type": "Question",
"name": "Les médicaments sont-ils toujours nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, certains patients peuvent gérer les symptômes avec des approches non médicamenteuses."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent provoquer des effets secondaires comme la somnolence."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces à long terme ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité peut varier, et un suivi régulier est souvent nécessaire pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fatigue chronique et des troubles de l'humeur comme l'anxiété."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il affecter la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil peuvent contribuer à des problèmes de santé mentale."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru d'autres maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les troubles du sommeil peuvent augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et des changements de mode de vie."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications implique souvent une approche multidisciplinaire incluant médecins et psychologues."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, des troubles neurologiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes sont souvent plus touchés que les femmes par ce syndrome."
}
},
{
"@type": "Question",
"name": "Les troubles du sommeil augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme l'apnée du sommeil peuvent augmenter le risque de ce syndrome."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les antidépresseurs, peuvent exacerber les symptômes."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise hygiène du sommeil peuvent augmenter le risque."
}
}
]
}
]
}
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Children's Neurosciences (T.R., M.L.), Evelina London Children's Hospital at Guy's and St Thomas' NHS Foundation Trust, King's Health Partners Academic Health Science Centre; Department Women and Children's Health (T.R., M.L.), School of Life Course Sciences (SoLCS), King's College London, UK; Division of Neurology (E.A.Y.), Department of Pediatrics, Neurosciences and Mental Health (RI), The Hospital for Sick Children; Faculty of Medicine (E.A.Y.), The University of Toronto, Ontario, Canada; Department of Pediatrics (Y.K.) and Department of Neurology (Y.K.), Memorial Sloan Kettering Cancer Center, New York, NY; Department of Pediatrics (Y.K.), Weill Medical College of Cornell University, New York; Children and Young People's Unit (Paola Angelini), The Royal Marsden, Downs Road, Sutton, Surrey; UCL Great Ormond Street Institute of Child Health (C.H.), Department of Neurology, Great Ormond Street Hospital for Children, London; Oxford Autoimmune Neurology Group (S.R.I.), Nuffield Department of Clinical Neurosciences, University of Oxford; Department of Neurology (S.R.I.), Oxford University Hospitals NHS Foundation Trust, UK; SiRIC RTOP (G.S.), Translational Research Department, PSL Research University, Institut Curie Research Center; INSERM U830 (G.S.), PSL Research University, Institut Curie Research Center; SIREDO Center: Care (G.S.), Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France; Department of Child and Adolescent Psychiatry (P.S.), King's College London; Centre for Interventional Paediatric Psychopharmacology and Rare Diseases (CIPPRD) Research Team (P.S.), South London and Maudsley NHS Foundation Trust, London, UK; Baylor College of Medicine (T.L.), Texas Children's Hospital, Houston; Kids Neuroscience Centre (R.C.D.), The Children's Hospital at Westmead, Westmead, NSW, Australia; TY Nelson Department of Neurology and Neurosurgery (R.C.D.), The Children's Hospital at Westmead; The Children's Hospital at Westmead Clinical School (R.C.D.), Faculty of Medicine, University of Sydney, NSW, Australia; Pediatric Neurology Department (K.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Saclay, Bicêtre Hospital; National Referral Center for Rare Inflammatory and Auto-Immune Brain and Spinal Diseases (K.D.); Inserm UMR 1184 (K.D.), Immunology of Viral Infections and Autoimmune Diseases, CEA, IDMIT, Le Kremlin Bicêtre, France; Department of Pediatric Hematology and Oncology (B.H.), University Children's Hospital, Koln; Division of Child Neurology (A.K.), University Children's Hospital Bern Inselspital, University of Bern; Department of Pediatric Neurology (A.K.), University Children's Hospital Basel, Switzerland; Department of Pediatrics (Pedro de Alarcon), University of Illinois College of Medicine at Peoria, Peoria IL; Department of Neurology (M.P.G.), Boston Children's Hospital, Harvard Medical School, MA; Division of Neurology (W.G.M.), Department of Pediatrics, Children's Hospital Los Angeles; and Department of Neurology (W.G.M.), Keck School of Medicine at the University of Southern California, Los Angeles.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
From the Department of Neurology (J.D.S.), Massachusetts General Hospital, Boston; Department of Neurology (J.D.S., J.M.K., M.P.G.), Boston Children's Hospital, MA; Harvard Medical School (J.D.S., K.D.M.), Boston, MA; Division of Neurology (J.D.S.), Department of Pediatrics, Children's Hospital of Los Angeles, CA; Department of Neurology (J.D.S.), Keck School of Medicine at the University of Southern California, Los Angeles; Department of Pediatrics (R.C., T.C.C.), University of Utah School of Medicine, Salt Lake City; Department of Neurology and Neurotherapeutics (B.M.G.), The University of Texas Southwestern Medical Center at Dallas, TX; UCSF Weill Institute for Neurosciences (E.W.), Department of Neurology, University of California San Francisco, CA; Computational Health Informatics Program (S.W.K., K.D.M.), Boston Children's Hospital, MA; and Department of Pediatrics (S.W.K., K.D.M.), Boston Children's Hospital, MA. jdsantoro@chla.usc.edu.
Publications dans "Syndrome des mouvements périodiques nocturnes des membres" :
Achilles tendinopathy [AT] is a functional problem characterised by swelling and pain above the Achilles tendon insertion region. In individuals with AT, PRP or platelet-rich plasma can be used as an ...
We did a literature search for randomised controlled trials [RCTs] that contrasted the effectiveness of PRP with that of eccentric exercise and placebo injections as treatment for AT in databases such...
We included five RCTs in this meta-analysis. There was no significant difference in the VISA-A between the PRP and placebo groups at 12 weeks, 24 weeks and 1 year after treatment. However, at 6 weeks ...
PRP injection is an effective treatment for chronic AT. It has a unique potential for increasing function and reducing discomfort in AT patients....
Platelet-rich plasma (PRP), which is widely used in many dermatologic conditions, has also been used in the treatment of melasma in recent years. The objective of this study is to determine the effica...
Autologous platelet-rich plasma (PRP) consists of plasma and a concentrate of platelets extracted from fresh whole blood of the person being treated. Research has suggested that intrauterine or intrao...
To assess the effectiveness and safety of intrauterine and intraovarian infusion/injection of platelet-rich plasma in infertile women undergoing assisted reproductive technology cycles....
We searched the Cochrane Gynaecology and Fertility Group's Specialised Register, CENTRAL, MEDLINE, Embase, and the Epistemonikos database in January 2023. We also searched the reference lists of relev...
We included randomized controlled trials (RCTs) that evaluated the application of PRP in the uterine cavity, ovaries, or both versus no intervention, placebo, or any other intervention (either mechani...
We followed standard methodological procedures recommended by Cochrane, including use of the updated risk of bias tool (RoB 2). The primary outcomes were live birth (or ongoing pregnancy) and miscarri...
We included 12 parallel-group RCTs that recruited a total of 1069 women. We identified three different comparison groups. Using GRADE, we assessed the certainty of evidence as very low for almost all ...
We are uncertain about the effect of intrauterine or intraovarian administration of PRP on outcomes of assisted reproduction technology in infertile women. The pooled results should be interpreted wit...
With the aging of the population and changes in lifestyle, the incidence of spine-related diseases is increasing, which has become a major global public health problem; this results in a huge economic...
If we could choose a single non-fatal medical condition to find a better solution that would make the greatest impact on global health it would be a solution for degenerative disc disease (DDD) - the ...
Muscle injury in sport results in significant lost time and potential for reinjury for athletes. Autologous blood product, namely, platelet-rich plasma (PRP), has been investigated for possible augmen...
Plasma cell vulvitis is a rare inflammatory disorder of the vulva with an unknown aetiology, characterised by mucosal inflammation. It commonly manifests as pain, itching, dyspareunia, and dysuria and...
case report; immunosuppressant; platelet-rich plasma; vulvitis....
In recent years, minimally invasive and non-invasive rejuvenation methods have been welcomed. PRP has been used widely for skin rejuvenation, but there are few studies on PRP for lip rejuvenation....
The objective of this study was to investigate the preliminary effects of PRP for lip rejuvenation....
Between October 2018 and April 2023, 15 participants with lip aging (1 male, 14 females; range 27-58 years) were treated with PRP. The follow-up time was 3 to 24months. After 3 to 6 times treatments, ...
According to the beauty seekers and Surgeons 'evaluation, the aging characteristics of the lips of the 15 beauty seekers have been improved to varying degrees. The most obvious improvement was that th...
The results of this study revealed promising evidence of PRP as an effective option on lip rejuvenation. However, large, multi-center, controlled, long term, pilot studies are required to confirm the ...
Platelet-rich plasma (PRP) is an autologous blood-derived product that has gained significant attention in the treatment of tendinopathies as one of many treatment modalities in the field of regenerat...
Platelet-rich plasma (PRP), a blood-based product containing platelets and growth factors, is being utilized to treat numerous non-hemostatic disorders. Studies have explored the use of PRP to provide...
The paper reviews the various applications of PRP, including factors to consider before using PRP therapy, and provides an extensive list of PRP applications....
The administration of PRP as a standalone treatment or as a co-therapy results in observed positive outcomes. However, there is a lack of standardization for PRP preparation, increasing the risks for ...
The use of PRP is indeed an option for regenerative therapy, but more research is needed before it can fully be recommended as a primary treatment modality....